Florida Endocrine Tumor Symposium Brings Leading Experts in Thyroid, Parathyroid and Adrenal Disease to Tampa Oct. 23–24

CME-accredited symposium will offer case-based education, emerging treatment strategies and direct access to national and international endocrine tumor experts

TAMPA, FL, UNITED STATES, September 10, 2026 /EINPresswire.com/ -- Registration is now open for the Florida Endocrine Tumor Symposium (FETS), a focused CME-accredited educational program bringing together leading experts in thyroid, parathyroid and adrenal disease for advanced, case-based discussions designed to translate the latest knowledge into clinical practice.
The symposium will be held October 23–24, 2026, in Tampa, Florida, beginning with an opening reception Friday evening at the Hospital for Endocrine Surgery, followed by a full day of scientific programming on Saturday. Attendees may earn 7.5 AMA PRA Category 1 Credits.

Designed for endocrinologists, endocrine and head and neck surgeons, oncologists, primary care physicians, fellows, advanced practice providers, nurse practitioners and other healthcare professionals involved in caring for patients with endocrine tumors and diseases, the symposium will emphasize practical clinical education across thyroid, parathyroid and adrenal disease.

Unlike a large national medical congress, the Florida Endocrine Tumor Symposium is intentionally designed as a focused meeting of approximately 100–150 clinicians, creating opportunities for meaningful interaction with faculty, multidisciplinary discussion and professional networking.

“This symposium is designed to bring clinicians together for the kind of focused, case-based discussion that can have a direct impact on how we evaluate and care for patients with complex endocrine disease,” said Jamie Mitchell, MD, FACS, of the Norman Parathyroid Center at the Hospital for Endocrine Surgery.

National and International Faculty

The program brings together recognized experts from leading academic and specialty centers. Featured speakers include Constantine A. Stratakis, MD, D(Med)Sci; Steven I. Sherman, MD; Tobias Carling, MD, PhD; Jamie Mitchell, MD; Gary Clayman, MD; Eyas Alkhalili, MD; Valentina Tarasova, MD; Tae-Yon Sung, MD; Manuel C. Sainz de la Pena, MD; and Jesus L. Penabad, MD.

Saturday's scientific program will explore a range of timely clinical issues, including recurrent and persistent primary hyperparathyroidism; adrenal hypercortisolism and Cushing syndrome; function-preserving adrenal surgery; osteoporosis in endocrine tumor disease; molecular diagnostics for thyroid nodules; advanced thyroid cancer surgery; robotic thyroid surgery; and targeted therapies and immunotherapy for advanced thyroid cancer. Fellow case presentations and an interactive faculty Q&A will provide additional opportunities for clinical discussion.

Two keynote presentations will highlight the program. Constantine Stratakis, MD, D(Med)Sci, will address Adrenal Hypercortisolism: From MACS to Severe Cushing Syndrome, while Steven I. Sherman, MD, of MD Anderson Cancer Center, will discuss cutting-edge therapies for advanced thyroid cancer, including targeted therapies and immunotherapy.

An Inside Look at the Hospital for Endocrine Surgery

The symposium experience begins Friday, October 23, with an Opening Night Reception at the Hospital for Endocrine Surgery, described by the conference as the nation's highest-volume hospital for thyroid, parathyroid and adrenal surgery.

Attendees will have an opportunity to tour the hospital, meet faculty and fellow participants, and network over cocktails and hors d'oeuvres in a relaxed setting. Transportation from the conference host hotel will be provided.

Registration Now Open

Physicians and other healthcare professionals interested in attending are encouraged to register early because of the symposium's intentionally limited size.

For complete program information and registration:

Register for the Florida Endocrine Tumor Symposium
Additional conference information and the complete scientific program are available through the Florida Endocrine Tumor Symposium website https://www.fl-endo.com/.

About the Florida Endocrine Tumor Symposium

The Florida Endocrine Tumor Symposium is a focused CME educational meeting dedicated to advancing the diagnosis and treatment of thyroid, parathyroid and adrenal diseases and cancers. Through case-based education, multidisciplinary discussion and interaction with national and international experts, the symposium is designed to provide clinicians with practical insights that can be applied to patient care.

Diana Van Leuven
The VAN LEUVEN Company
+1 314-409-9051
email us here